• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LUTONIX, INC LUTONIX 035AV DRUG COATED PTA DILATION CATHETER; DRUG COATED BALLOON PTA CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LUTONIX, INC LUTONIX 035AV DRUG COATED PTA DILATION CATHETER; DRUG COATED BALLOON PTA CATHETER Back to Search Results
Model Number 9010
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Hemorrhage/Blood Loss/Bleeding (1888); Restenosis (4576)
Date of Event 03/05/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
H10: as the lot number for the device was provided, a review of the device history records will be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.H11: section a through f ¿ the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H10: as this malfunction/serious injury is considered one event identified by the dealer; only one mdr report will be submitted for the reported quantity affected of (lutonix drug coated balloon).
 
Event or Problem Description
On (b)(6) 2025 a patient underwent the lutonix drug coated balloon procedure.It was reported through the results of a clinical trial that one year three months and fifteen days post an index procedure completion using a drug-coated balloon catheter on the left upper arm cephalic vein lesion, the subject had an adverse event of prolonged bleeding.The adverse event relationship details were not provided.Reportedly, a av access circuit re-intervention was performed for elevated venous pressures and prolonged bleeding.A standard pta and lutonix dcb was used in re-intervention.The re-intervention was successful and the current status of the patient was unknown.
 
Additional Manufacturer Narrative
H11: manufacturing review: a manufacturing review was not required as this is the only complaint reported to date for this product and lot.Investigation summary: the physical device was not returned for evaluation.No photos were provided for review.Therefore, the investigation is inconclusive for the reported failure as no objective evidence was provided for review.Based upon the available information, the definitive root cause is unknown.Labelling review: as the reported event did not allege a labeling or use related issue, a labeling review is not required.B5, g3, h6 (patient, component, method).Section a through f ¿ the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
It was reported through the results of a clinical trial that one year three months and fifteen days post an index procedure completion using a drug-coated balloon catheter on the left upper arm cephalic vein lesion, the subject had an adverse event of prolonged bleeding cephalic vein.Reportedly, the adverse event relationship was not related to study device and study procedure but possibly related to av access circuit.It was further reported that, an av access circuit re-intervention was performed for elevated venous pressures and prolonged bleeding.A standard pta and lutonix dcb was used in re-intervention on the target lesion on cephalic vein with initial stenosis of 50% and final residual stenosis of 10% and new lesion within the access circuit on the cephalic vein with initial stenosis of 70% and final residual stenosis of 5%.The re-intervention was successful and the current status of the patient was unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LUTONIX 035AV DRUG COATED PTA DILATION CATHETER
Common Device Name
DRUG COATED BALLOON PTA CATHETER
Manufacturer (Section D)
LUTONIX, INC
9409 science center dr
new hope MN 55428
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury 12804
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key22163976
Report Number3006513822-2025-00037
Device Sequence Number7484345
Product Code PRC
UDI-Device Identifier00801741135484
UDI-Public(01)00801741135484(17)250727(10)GFHS2523
Combination Product (Y/N)Y
Initial Reporter StatePA
Initial Reporter CountryUS
PMA/510(K) Number
P170003
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Other,Study
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 06/17/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/27/2025
Device Model Number9010
Device Catalogue NumberLX3575940V
Device Lot NumberGFHS2523
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/13/2025
Supplement Date Received by Manufacturer09/12/2025
Initial Report FDA Received Date06/07/2025
Supplement Report FDA Received Date09/16/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age61 YR
Patient SexMale
Patient Weight102 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-